Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1002/jmv.26814

http://scihub22266oqcxt.onion/10.1002/jmv.26814
suck pdf from google scholar
33475167!8014870!33475167
unlimited free pdf from europmc33475167    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33475167      J+Med+Virol 2021 ; 93 (5): 2722-2734
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Targeting SARS-CoV-2 viral proteases as a therapeutic strategy to treat COVID-19 #MMPMID33475167
  • Anirudhan V; Lee H; Cheng H; Cooper L; Rong L
  • J Med Virol 2021[May]; 93 (5): 2722-2734 PMID33475167show ga
  • The 21st century has witnessed three outbreaks of coronavirus (CoVs) infections caused by severe acute respiratory syndrome (SARS)-CoV, Middle East respiratory syndrome (MERS)-CoV, and SARS-CoV-2. Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, spreads rapidly and since the discovery of the first COVID-19 infection in December 2019, has caused 1.2 million deaths worldwide and 226,777 deaths in the United States alone. The high amino acid similarity between SARS-CoV and SARS-CoV-2 viral proteins supports testing therapeutic molecules that were designed to treat SARS infections during the 2003 epidemic. In this review, we provide information on possible COVID-19 treatment strategies that act via inhibition of the two essential proteins of the virus, 3C-like protease (3CL(pro) ) or papain-like protease (PL(pro) ).
  • |*COVID-19 Drug Treatment[MESH]
  • |Antiviral Agents/*therapeutic use[MESH]
  • |COVID-19/epidemiology[MESH]
  • |Coronavirus 3C Proteases/chemistry/drug effects/genetics[MESH]
  • |Coronavirus Papain-Like Proteases/chemistry/drug effects/genetics[MESH]
  • |Humans[MESH]
  • |Middle East Respiratory Syndrome Coronavirus[MESH]
  • |Protease Inhibitors/therapeutic use[MESH]
  • |SARS-CoV-2/genetics/metabolism[MESH]
  • |Viral Nonstructural Proteins/chemistry/genetics[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box